Navigation Links
Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
Date:10/27/2013

out Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11270269.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
2. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
3. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
4. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
5. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
6. Kantar Health Launches CancerMPact Biomarker Analysis
7. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
8. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
9. Kantar Health to Present at PBIRG Annual General Meeting
10. AACR honors Hagop Kantarjian for outstanding clinical research
11. Kantar Health to Participate in CIO Summit of America Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 The panel of independent experts ... 98 candidates short-listed for the awards presented tonight at ... was fierce but the best-of-the-best can now be revealed ... Group , Volvo swept rivals aside by taking the ... unanimous praise from our panel of expert judges., Stand ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Acne is ... (“bacne”) can be particularly stubborn to eliminate and hard to ... most common in teens and young adults, in the years ... produce sebum, or oil,” says Jayme Bashian, director and lead ... characteristic pimples, blackheads and cysts of acne are caused by ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional organizations ... business are rewriting the rules for business as we ... traditional businesses to take on a more agile approach ... On top of this there is a growing ... bring new innovation and approaches to business. , The ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
Breaking Medicine News(10 mins):Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2
... benefits of short-term use of hormone therapy in menopausal women ... of life, but they may also shorten their life expectancy ... not to use hormone therapy can be a difficult decision. ... but are the risks worth the benefits? Question researchers . ...
... awareness is needed about the risks of certain prescribed drugs ... // multiple chronic conditions and take several drugs concurrently many ... ,Researchers conducted a study to look at medication prescriptions ... more than 20 percent of the people filled a prescription ...
... with hemophilia arthropathy, a severe form of hemophilia that ... // than other children for developing osteoporosis in ... in preventing osteoporosis from hitting these children, say researchers. ... activities than was previously advised by doctors. An exercise ...
... a tracheoesophageal puncture (TEP), is an incision between the ... small plastic //or silicone valve , researchers say this ... and neck cancer patients who have had their voice ... combined with post operative speech rehabilitation therapy, can provide ...
... have now found a way to genetically engineer the common ... healthy ones intact.// They did this by modifying one gene, ... had to boost the activity of another gene to ensure ... say, “When the virus infects cells, it takes the altered ...
... get a prescription for a potentially lifesaving drug after ... which the heart has trouble pumping blood. // ... who don’t receive an angiotensin-converting enzyme inhibitor are 14-percent ... who do get the drug. ACE inhibitors work by ...
Cached Medicine News:
(Date:6/3/2015)...  (AHIP Institute Booth 1021) --  Availity , the ... a wide range of information to help health plans ... Health Insurance Plan,s (AHIP,s) 2015 Institute , June 3-5, ... Availity released a special report to AHIP Institute ... opportunities." The report identifies billions of dollars ...
(Date:6/3/2015)... MARLBOROUGH, Mass. , June 3, 2015 ... RXII ), a biotechnology company focused on ... the areas of dermatology and ophthalmology, today announced ... from the United States Patent and Trademark ... platform (sd‑rxRNA®). The patent, titled "RNA Interference ...
(Date:6/3/2015)... 3, 2015  EIP Pharma LLC ( www.eippharma.com ) ... development of VX-745 in Alzheimer,s disease (AD) is underway.  ... potent inhibitor of the alpha isoform of the protein ... "Recent human genetic data demonstrate that inflammation ... symptomatic Alzheimer,s, while the science also indicates the p38 ...
Breaking Medicine Technology:Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or ... related services, today announced that it received a letter ... Amex of the "record date" for the 2012 Annual ... the record date for the Company,s 2012 Annual Meeting, ...
... (NASDAQ: ROCM ) is pleased to announce an addition ... of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip ... very latest Magic3 technology. It provides the ... designed curved tip configuration. The Coude tip is ...
Cached Medicine Technology:InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter 2
4 mm x 9 mm tip....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Medicine Products: